Piper Jaffray lowered its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Tetraphase Pharmaceuticals (TTPH) PT Lowered to $6 at H.C. WainwrightFebruary 14, 2018 7:16 AM Tetraphase Pharmaceuticals (TTPH) PT Lowered to $6 at Stifel; Path Forward Complicated, But Still ThereFebruary 14, 2018 6:28 AM Tetraphase Pharmaceuticals (TTPH) PT Lowered to $6 at B.Riley/FBR, 'IGNITE3 Failure Limits but Does Not Quash Eravacycline Opportunity'February 14, 2018 4:29 AM BMO Capital Downgrades Tetraphase Pharmaceuticals (TTPH) to Market PerformFebruary 14, 2018 4:05 AM